24-hydroxycholesterol has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Fang, A; Fu, ZF; Sui, B; Wang, C; Wang, Z; Yuan, Y; Zhang, R; Zhang, Y; Zhao, L; Zhou, M; Zhu, Y | 1 |
1 other study(ies) available for 24-hydroxycholesterol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The CH24H metabolite, 24HC, blocks viral entry by disrupting intracellular cholesterol homeostasis.
Topics: Animals; Cholesterol; Cholesterol 24-Hydroxylase; COVID-19; Homeostasis; Mice; SARS-CoV-2; Virus Internalization | 2023 |